George Freeman Parliamentary Under Secretary of State for Life Sciences Department of Health Richmond House 79 Whitehall London

First Page		Document Content
Date: 2016-06-10 08:58:29 Biology Health Emerging technologies Department of Health Biotechnology Developmental biology Regenerative biomedicine Medicines and Healthcare products Regulatory Agency European Medicines Agency Stem cell National Institute for Biological Standards and Control Gene therapy		George Freeman Parliamentary Under Secretary of State for Life Sciences Department of Health Richmond House 79 Whitehall London Add to Reading List Source URL: ct.catapult.org.uk Download Document from Source Website File Size: 284,27 KB Share Document on Facebook

	Biotechnology, BS "DBEFNJD.BQ 5IF"DBEFNJD.BQTFSWFTBTBTVHHFTUFEDPVSTFTFRVFODFPOMZ4UVEFOUTBSFOPUMJNJUFEUPUIJTQMBOJUJTNFBOUUPCFVTFEBT DocID: 1xTqy - View Document
	PDF Document DocID: 1wroO - View Document
	Building A Better Mousetrap: Patenting Biotechnology In The European Community DocID: 1vr7C - View Document
	BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prod DocID: 1vq6b - View Document
	Biotechnology Consultation Agency Response Letter BNF DocID: 1vpUZ - View Document